Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial. Erlanger DM, Kaushik T, Caruso LS, Benedict RHB, Foley FW, Wilken J, Cadavid D, DeLuca J J Neurol Sci. 2014 Mar 11. PMID: 24656433. Abstract CommentRecommendBookmarkWatch